Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain-Barré syndrome in chicken

Medical Microbiology and Immunology

Volumn 201, Issue 2, 2012, Pages 177-187

  Nyati, Kishan K ^a   Prasad, Kashi N ^a   Kharwar, Nagendra K ^a   Soni, Priyanka ^b   Husain, Nuzhat ^b   Agrawal, Vinita ^a   Jain, Arun K ^c  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b Dr RML Institute of Medical Sciences   (India)

^c SAFDARJUNG HOSPITAL   (India)

Author keywords

Campylobacter jejuni; Chicken model; Guillain Barr syndrome; Sciatic nerve pathology

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MYELIN; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CHICKEN; CONTROLLED STUDY; DEMYELINATION; DIARRHEA; GENE; GENE EXPRESSION; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; IFN GAMMA GENE; IL 10 GENE; IL 1BETA GENE; IL 2 GENE; IL 4 GENE; IL 6 GENE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NERVE FIBER; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE; TGF BETA2 GENE; TH1 CELL; TH2 CELL; TNF ALPHA GENE;

ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHICKENS; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GUILLAIN-BARRE SYNDROME; HISTOCYTOCHEMISTRY; LYMPHOCYTES; MICROSCOPY, ELECTRON, TRANSMISSION; PARALYSIS; POULTRY DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCIATIC NERVE; TH1 CELLS; TH2 CELLS;

EID: 84863459466     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-011-0220-3     Document Type: Article

References (43)

1. Linton D, Lawson AJ, Owen RJ, Stanley J (1997) PCR detection, identification to species level, and fingerprinting of Campylobacter jejuni and Campylobacter coli direct from diarrheic samples. J Clin Microbiol 35:2568-2572
2. Oberhelman RA, Taylor DN (2000) Campylobacter infections in developing countries, 2nd edn. ASM Press, Washington, DC
3. Nachamkin I, Allos BM, Ho T (1998) Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev 11:555-567
4. Thomas PK (1992) The Guillain-Barré syndrome: no longer a simple concept. J Neurol 239:361-362
5. Hughes RA (1995) The concept and classification of Guillain-Barré syndrome and related disorders. Rev Neurol (Paris) 151:291-294
6. Islam Z, Jacobs BC, van Belkum A, Mohammad QD, Islam MB, Herbrink P, Diorditsa S, Luby SP, Talukder KA, Endtz HP (2010) Axonal variant of Guillain-Barré syndrome associated with Campylobacter infection in Bangladesh. Neurology 74:581-587
7. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV (2001) Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 56:758-765
8. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N (2000) Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624-631
9. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM (1995) Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597-605
10. Koski CL (1997) Mechanisms of Schwann cell damage in inflammatory neuropathy. J Infect Dis 176:S169-S172
11. Ekerfelt C, Dahle C, Weissert R, Kvarnstrom M, Olsson T, Ernerudh J (2001) Transfer of myelin-specific cells deviated in vitro towards IL-4 production ameliorates ongoing experimental allergic neuritis. Clin Exp Immunol 123:112-118
12. Nyati KK, Prasad KN, Rizwan A, Verma A, Paliwal VK (2011) Th1 and Th2 response to Campylobacter jejuni antigen in Guillain-Barré syndrome. Arch Neurol 68:445-452
13. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, Mishu B, Cornblath DR, Macko C, McKhann GM, Asbury AK (1996) Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 39:17-28
14. Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, Yang C, Tian M, Mishu B, Cornblath DR (1995) Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118:577-595
15. Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WJ (1993) Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 116:185-192
16. Berciano J, Coria F, Monton F, Calleja J, Figols J, LaFarga M (1993) Axonal form of Guillain-Barré syndrome: evidence for macrophage- associated demyelination. Muscle Nerve 16:744-751
17. Kaldor J, Speed BR (1984) Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br Med J (Clin Res Ed) 288:1867-1870
18. Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y, Nakanishi H (1993) Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to penner serogroup 19 and contain beta-N- acetylglucosamine residues. Ann Neurol 33:243-247
19. Li CY, Xue P, Tian WQ, Liu RC, Yang C (1996) Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 61:279-284
20. Nyati KK, Prasad KN, Rizwan A, Verma A, Paliwal VK, Pradhan S (2010) Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome. Med Microbiol Immunol 199:109-116
21. Sinha S, Prasad KN, Pradhan S, Jain D, Jha S (2004) Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome. Trans R Soc Trop Med Hyg 98:342-346
22. Jain D, Prasad KN, Sinha S, Husain N (2008) Differences in virulence attributes between cytolethal distending toxin positive and negative Campylobacter jejuni strains. J Med Microbiol 57:267-272
23. Bader SR, Kothlow S, Trapp S, Schwarz SC, Philipp HC, Weigend S, Sharifi AR, Preisinger R, Schmahl W, Kaspers B, Matiasek K (2010) Acute paretic syndrome in juvenile white leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans. J Neuroinflamm 7:7
24. Maurer M, Toyka KV, Gold R (2002) Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models. Neuromuscul Disord 12:405-414
25. Maier H, Schmidbauer M, Pfausler B, Schmutzhard E, Budka H (1997) Central nervous system pathology in patients with the Guillain-Barre syndrome. Brain 120:451-464
26. Shahrizaila N, Yuki N (2011) Guillain-barre syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder. J Biomed Biotechnol 2011:1-5
27. Chowdhury D, Arora A (2001) Axonal Guillain-Barré syndrome: a critical review. Acta Neurol Scand 103:267-277
28. Honavar M, Tharakan JK, Hughes RA, Leibowitz S, Winer JB (1991) A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review. Brain 114:1245-1269
29. Kahl KG, Kruse N, Toyka KV, Rieckmann P (2002) Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis. J Neurol Sci 200:53-55
30. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172:1193-1200
31. Creange A, Belec L, Clair B, Raphael JC, Gherardi RK (1996) Circulating tumor necrosis factor (TNF)-alpha and soluble TNFalpha receptors in patients with Guillain-Barré syndrome. J Neuroimmunol 68:95-99
32. Hartung HP, Pollard JD, Harvey GK, Toyka KV (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome: part I. Muscle Nerve 18:137-153
33. Jones MA, Totemeyer S, Maskell DJ, Bryant CE, Barrow PA (2003) Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni. Infect Immun 71:2626-2633
34. Hu L, Bray MD, Osorio M, Kopecko DJ (2006) Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infect Immun 74:2697-2705
35. Hickey TE, Majam G, Guerry P (2005) Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect Immun 73:5194-5197
36. Strierter RM, Standiford TJ, Rolfe MW, Lynch JP III, Metinko AP, Kunkel SL (1992) Cytokines in pulmonary injury. Marcel Dekker, New York
37. Abbas A, Lichtman A (2003) Cellular and molecular immunology, 5th edn. Saunders, Philadelphia
38. Baqar S, Pacheco ND, Rollwagen FM (1993) Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines. Antimicrob Agents Chemother 37:2688-2692
39. Al-Banna N, Raghupathy R, Albert MJ (2008) Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection. Clin Vaccine Immunol 15:1780-1787
40. Creange A, Belec L, Clair B, Degos JD, Raphael JC, Gherardi RK (1998) Circulating transforming growth factor beta 1 (TGFbeta1) in Guillain- Barré syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry 64:162-165
41. Zhu J, Mix E, Link H (1998) Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome. J Neuroimmunol 84:40-52
42. Koski CL, Chou DK, Jungalwala FB (1989) Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J Clin Invest 84:280-287
43. Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-2095